Reducing major depression in children at high risk: opportunities for prevention

Gary A Keller1, Diane T Gottlieb

  • 1University of Vermont, USA. gary.keller@uvm.edu

Insights

Treating parental Major Depressive Disorder (MDD) can protect children from developing psychiatric illness. Preventive interventions, including improved parenting skills and child coping strategies, also reduce offspring risk for MDD.

Area of Science:

  • Child and Adolescent Psychiatry
  • Mental Health Research
  • Family Psychology

Background:

  • Parental Major Depressive Disorder (MDD) significantly increases offspring risk for psychiatric conditions, including a fourfold higher risk for MDD.
  • Public health and mental health professionals are increasingly concerned about the profound negative impact of parental MDD on children's well-being.
  • Understanding the link between parental mental health and child psychopathology is crucial for developing effective interventions.

Purpose of the Study:

  • To review the scientific literature on strategies to reduce the risk of psychiatric illness in children of parents with MDD.
  • To examine the effectiveness of treating parental depression in mitigating risks to offspring.
  • To explore the impact of preventive interventions on offspring psychopathology.

Main Methods:

  • Comprehensive literature search using PubMed, Cochrane Database, Medline, and PsycLit databases.
  • Inclusion of randomized controlled studies, review articles, and meta-analyses to provide a critical overview.
  • Keywords included 'depression,' 'prevention,' 'treatments,' 'depression in families,' 'family interaction,' and 'adolescents'.

Main Results:

  • Effective treatment of parental MDD is associated with a reduced risk of psychopathology in children.
  • Treatments addressing co-occurring MDD in both parents and children are supported by scientific evidence.
  • Preventive interventions for high-risk adolescents demonstrably reduce the incidence of MDD.

Conclusions:

  • Clinical focus on improved treatment for parental MDD offers a significant benefit in reducing offspring psychopathology.
  • Targeting parenting skills and enhancing children's coping mechanisms for parental illness can effectively lower MDD risk in offspring.
  • Integrating family-centered approaches in mental health care is essential for protecting children of depressed parents.
Abstract

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...